Predicting pathological response to neoadjuvant or conversion chemoimmunotherapy in stage IB-III non-small cell lung cancer patients using radiomic features.
Yang N, Yue HL, Zhang BH, Chen J, Chu Q, Wang JX, Yu XP, Jian L, Bin YW, Liu SY, Liu J, Zeng L, Yang HY, Zhou CH, Jiang WJ, Liu L, Zhang YC, Xiong Y, Wang Z.
Yang N, et al. Among authors: yue hl.
Thorac Cancer. 2023 Oct;14(28):2869-2876. doi: 10.1111/1759-7714.15052. Epub 2023 Aug 19.
Thorac Cancer. 2023.
PMID: 37596822
Free PMC article.